Table 1

Patient demographics and tumor characteristics
Total (%) Male (%) Female (%)
Clinical features N = 102 N = 82 N = 20 P value
Sex
Male 82 (80.4)
Female 20 (19.6)
Age (Year) 0.348
Median [Range] 68 [29-86] 68 [29-84] 72[29-86]
29-49 18 (17.6) 16 (19.5) 2 (10.0)
50-79 73 (71.6) 59 (57.8) 14 (70.0)
79-86 11 (10.8) 7 (8.5) 4 (20.0)
Location 0.868
Upper 27 (26.5) 22 (26.8) 5 (33.3)
Middle + Lower 75 (73.5) 60 (73.2) 15 (66.6)
Operation method 0.454
Partial 64 (62.7) 50 (61.0) 14 (70.0)
Total 38 (37.3) 32 (39.0) 6 (30.0)
Curability 0.147
No residual tumors 87 (85.3) 72 (87.8) 15 (75.0)
Definite residual tumor 15 (14.7) 10 (12,2) 5 (25.0)
Clinical stage (TNM) 0.563
Stage I-III 82 (80.4) 65 (79.3) 17 (85.0)
Stage IV 20 (19.6) 17 (20.7) 3 (15.0)
Histological stage (TNM) 0.936
Stage II-III 86 (84.3) 69 (84.2) 17 (85.0)
Stage IV 16 (15.7) 13 (15.8) 3 (15.0)
Histological type
Intestinal 141 (100) 82 (100) 20 (100)
Diffuse 0 (0) 0 (0) 0 (0)
No of LN metastases 0.013
Median [Range] 4 [1-100] 4 [1-100] 2 [1-10]

Kochi et al.

Kochi et al. Diagnostic Pathology 2013 8:191   doi:10.1186/1746-1596-8-191

Open Data